Public-registry site landscape for NCT05587322, a Non-erosive Reflux Disease study sponsored by Braintree Laboratories. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT05587322 (registry record) |
| Sponsor | Braintree Laboratories |
| Condition(s) | Non-erosive Reflux Disease |
| Phase | PHASE3 |
| Listed sites | 112 |
| Site countries | United States |
Eichor generates a preliminary site-risk snapshot for NCT05587322 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →